Diagnostic discrimination between graft-related and non-graft-related perioperative myocardial infarction with cardiac troponin I after coronary artery bypass surgery

Eur Heart J. 2005 Nov;26(22):2440-7. doi: 10.1093/eurheartj/ehi437. Epub 2005 Aug 8.

Abstract

Aims: The rise of markers for myocardial injury indicates early graft-related or non-graft-related perioperative myocardial infarction (PMI) after coronary artery bypass grafting (CABG). A diagnostic discrimination between these two situations may enable adequate therapeutic measures, limiting myocardial damage, and improving outcome.

Methods and results: In a prospective study, 94 among 3308 consecutive CABG patients underwent acute reangiography because of evidence of PMI. Of these 94 patients, 56 had graft-related PMI (group 1), 38 patients had non-graft-related PMI (group 2), and 95 patients without evidence of PMI and angiographically patent grafts served as control (group 3). Cardiac troponin I (cTnI), creatine kinase (CK), and its MB fraction were determined. CTnI, but not CK/CK-MB levels were significantly higher in group 1 than in groups 2 and 3 at 12 and 24 h after aortic unclamping (P<0.0001). Receiver operating characteristic and multivariable logistic regression analyses indicated cTnI as the best discriminator between PMI 'in general' and 'inherent' release of cTnI after CABG with a cut-off value of 10.5 ng/mL and between graft-related and non-graft-related PMI with a cut-off value of 35.5 ng/mL.

Conclusion: Perioperative cTnI elevation after CABG separates among patients with graft-related, non-graft-related, and without PMI, however, not earlier than 12 h after surgery.

MeSH terms

  • Aged
  • Biomarkers / blood
  • Case-Control Studies
  • Coronary Angiography
  • Coronary Artery Bypass / adverse effects*
  • Creatine Kinase / blood
  • Creatine Kinase, MB Form / blood
  • Female
  • Graft Rejection / blood
  • Graft Rejection / etiology
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction / diagnosis*
  • Myocardial Infarction / etiology
  • Postoperative Care / methods
  • ROC Curve
  • Retreatment
  • Sensitivity and Specificity
  • Troponin I / blood*

Substances

  • Biomarkers
  • Troponin I
  • Creatine Kinase
  • Creatine Kinase, MB Form